The FDA approved a new Alzheimer's treatment called donanemab on Tuesday. It is designed to help patients in the early stages of the disease. CBS News chief medical correspondent Dr. Jon LaPook explains what to know.

Each weekday morning, "CBS Mornings" cohosts Gayle King, Tony Dokoupil and Nate Burleson bring you the latest breaking news, smart conversation and indepth feature reporting. "CBS Mornings" airs weekdays at 7 a.m. on CBS and stream it at 8 a.m. ET on the CBS News app.

Subscribe to "CBS Mornings" on YouTube:    / cbsmornings  
Watch CBS News 24/7: https://cbsnews.com/live/
Download the CBS News app: https://cbsnews.com/mobile/
Follow "CBS Mornings" on Instagram:   / cbsmornings  
Like "CBS Mornings" on Facebook:   / cbsmornings  
Follow "CBS Mornings" on X:   / cbsmornings  
Subscribe to our newsletter: https://cbsnews.com/newsletters/
Try Paramount+ free: https://paramountplus.com/?ftag=PPM0...

For video licensing inquiries, contact: [email protected]